# Heart Failure With Reduced Ejection Fraction: Adjuvant Therapy With Neurostimulation and Chlorella Pyrenoidosa (HD-tDCS)

> **NCT06528366** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Federal University of Paraíba** · enrollment: 28 (estimated)

## Conditions studied

- Heart Failure, Reduced Ejection Fraction
- Vitamin B12 Deficiency

## Interventions

- **DIETARY_SUPPLEMENT:** Chlorella pyrenoidosa
- **DEVICE:** High Definition Transcranial Direct Current Stimulation

## Key facts

- **NCT ID:** NCT06528366
- **Lead sponsor:** Federal University of Paraíba
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-09-26
- **Primary completion:** 2024-08-01
- **Final completion:** 2024-08-30
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2024-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06528366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06528366, "Heart Failure With Reduced Ejection Fraction: Adjuvant Therapy With Neurostimulation and Chlorella Pyrenoidosa (HD-tDCS)". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT06528366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
